Dimensions of humoral recognition factor depletion in carcinomatous patients.
D000328:Adult; D000368:Aged; D001681:Biological Assay; D001943:Breast Neoplasms / Q000276:immunology; D002822:Choriocarcinoma / Q000276:immunology; D003102:Colloids; D003110:Colonic Neoplasms / Q000276:immunology; D004655:Emulsions; D005153:Facial Neoplasms / Q000276:immunology; D005260:Female; D006048:Gold Colloid, Radioactive; D006084:Graft Rejection; D006801:Humans; D066298:In Vitro Techniques; D008055:Lipids; D008099:Liver / Q000166:cytology; D008264:Macrophages / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012157:Mononuclear Phagocyte System / Q000166:cytology / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*; D009895:Opsonin Proteins / Q000032:analysis*; D010587:Phagocytosis; D011247:Pregnancy; D012004:Rectal Neoplasms / Q000276:immunology; D013274:Stomach Neoplasms / Q000276:immunology; D013667:Technetium
D003102:Colloids; D004655:Emulsions; D006048:Gold Colloid, Radioactive; D008055:Lipids; D009895:Opsonin Proteins; D013667:Technetium